A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

被引：30
|
作者：
Powles, Thomas
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J.
Van der Heijden, Michiel Simon
Pous, Albert Font
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4506
引用
收藏
页数：1
相关论文
共 50 条
  • [31] S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer
    Singh, Parminder
    Catherine, Tangen
    Lerner, Seth P.
    McConkey, David
    Plets, Melissa
    Lucia, M. Scott
    Woods, Michael
    Bivalacqua, Trinity
    Kassouf, Wassim
    Bangs, Richard Carlton
    Thompson, Ian Murchie
    Black, Peter C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    Karaoglu, Aziz
    Oflazoglu, Utku
    Demir, Necla
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (01): : 58 - 63
  • [33] Neoadjuvant therapy for muscle-invasive bladder cancer
    Jain, Rohit K.
    Sonpavde, Guru
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 603 - 614
  • [34] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
    Peyrottes, Arthur
    Ouzaid, Idir
    Califano, Gianluigi
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [35] A phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Smith, Angela
    Coward, Matthew
    Kim, William
    Nielsen, Matthew
    Wallen, Eric
    Pruthi, Raj S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S129 - S129
  • [36] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] A phase II study of neoadjuvant erlotinib (tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Pearson, Matthew
    Nix, Jeffrey
    Kim, William
    Grigson, Gayle
    Wallen, Eric
    Pruthi, Raj S.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 119 - 119
  • [38] Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer
    Chen, Hualin
    Yang, Wenjie
    Xue, Xiaoqiang
    Li, Yingjie
    Jin, Zhaoheng
    Ji, Zhigang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] SAFETY AND EFFICACY OF BLADDER-PRESERVING THERAPY FOR MUSCLE INVASIVE BLADDER CANCER: A MONOINSTITUTIONAL EXPERIENCE
    Frassinelli, Luca
    Mazzeo, Ercole
    Sabbatini, Roberto
    Mucciarini, Claudia
    Alicino, Giulia
    Vernaleone, Marco
    Nicolini, Massimiliano
    Lohr, Frank
    Bruni, Alessio
    ANTICANCER RESEARCH, 2020, 40 (08) : 4640 - 4640
  • [40] Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study
    Mattioli, F
    Curotto, A
    Manfredi, V
    Gosmar, M
    Garbero, C
    Ambruosi, C
    Carmignani, G
    Martelli, A
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2493 - 2496
12345